Skip to content
Vardagsmagasin

Users Discontinuing Weight-Loss Jabs Put On Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

Image of medical injection and weighing machine
Obesity treatment involves ongoing approaches.

Fresh analysis indicates that individuals who stop using popular weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt conventional diet and exercise programs.

Findings released in a leading health publication demonstrates that while obese people frequently drop substantial amounts of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.

"Users using such medications should be informed of the potential of rapid weight regain when the treatment concludes," stated expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to pre-treatment mass within about a year and a half.

Comparing Therapies

The research, which examined dozens of trials involving thousands of patients, contrasted the effects of these new drugs with other pills.

Scientists note that people who lose weight through lifestyle changes alone generally experience a more gradual weight regain—perhaps 100 grams monthly—once they finish.

The Reason for the Fast Rebound

Nutrition scientists propose the mechanism of the drugs is key to understanding the heightened weight return.

The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.

"Artificially providing the hormone levels far above than the body's typical production may cause the body to produce less of its own natural GLP-1, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' leads to hunger is uncontrolled, making binge eating far more likely."

A Lifelong Issue?

Health authorities advise the jabs for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.

Professionals say that, due to the likelihood of relapse, the therapy should be considered ongoing.

This perspective is reinforced by drug manufacturers, who state that the findings "highlight the long-term character of excess weight," comparing it to managing conditions like diabetes.

User Experiences

Individuals who have come off the jabs explain a sudden return of cravings.

"I experienced a trigger that goes on and I was suddenly extremely hungry," said an individual.

The struggle is exacerbated if users have not established lasting lifestyle or habit modifications during treatment.

Widespread Interest

Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.

  • Use is greater among females than men.
  • The middle-aged demographic shows the greatest level of interest.
  • Many obtain the medications through private prescriptions rather than public health services.

In conclusion, researchers caution that while these medications are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on integrated lifestyle changes.

About the author

Janet Jones

Lena är en erfaren livsstilsbloggare med passion för heminredning och hållbarhet. Hon delar praktiska råd och kreativa idéer.

Vardagsmagasin

Type to search articles.